Mahnaz Sadeghi-Shabestari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mahnaz Sadeghi-Shabestari has a total of 309 co-authors. Here are the top co-authors by number of shared publications:
- Nima Rezaei
Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center Tehran University of Medical Sciences Tehran Iran
14 shared publications - Asghar Aghamohammadi
Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children’s Medical Center Hospital, Tehran University of Medical Sciences, Tehran, Iran
6 shared publications Lida Atarod
Imam Khomeini Hospital, Tehran University of Medical Sciences
5 shared publicationsMasoud Movahedi
5 shared publications- Mohammad Gharagozlou
Division of Allergy and Clinical Immunology, Department of Pediatrics, Children’s Medical Center Hospital, Tehran University of Medical Sciences, Tehran, Iran
5 shared publications Mohammad Nabavi
4 shared publications
Latest Publications
- 9 November 2025
- Published by Knowledge E DMCC in Iranian Journal of Allergy, Asthma and Immunology
- Vol. 24 (6) , 799-807
Measuring Dedicator of Cytokinesis 8 (DOCK8) Expression as a Flow Cytometry Biomarker for DOCK8 Deficiency Detection
The autosomal recessive form of hyperimmunoglobulin E syndrome (AR-HIES), caused by mutations in the DOCK8 (Dedicator of Cytokinesis 8) gene, presents a wide range of clinical manifestations and phenotypically overlaps with several types of combined immunodeficiency disorders characterized by elevated serum IgE levels. Due to the high rates of morbidity and mortality, as well as the potential curability through hematopoietic stem cell transplantation (HSCT), early and accurate differential diagnosis of this syndrome is crucial for optimal management and improved prognosis. Flow cytometry tests can be beneficial for early diagnosis of many inborn errors of immunity (IEIs), including this syndrome. This study, conducted for the first time on Iranian patients, investigated the expression of the DOCK8 protein. DOCK8 expression was assessed by flow cytometry in 14 patients (6 males and 8 females) with a clinical diagnosis of DOCK8 deficiency. The diagnosis was ultimately confirmed through genetic testing. The results showed that DOCK8 expression in patients was significantly lower compared to the healthy control group. Flow cytometric evaluation of DOCK8 protein expression offers a rapid and efficient diagnostic method with a sensitive detection range suitable for many cases. This approach can facilitate the diagnosis of DOCK8 deficiency, thereby enabling timely and effective disease management.
- 9 November 2025
- Published by Knowledge E DMCC in Iranian Journal of Allergy, Asthma and Immunology
- Vol. 24 (6) , 799-807
Measuring Dedicator of Cytokinesis 8 (DOCK8) Expression as a Flow Cytometry Biomarker for DOCK8 Deficiency Detection
The autosomal recessive form of hyperimmunoglobulin E syndrome (AR-HIES), caused by mutations in the DOCK8 (Dedicator of Cytokinesis 8) gene, presents a wide range of clinical manifestations and phenotypically overlaps with several types of combined immunodeficiency disorders characterized by elevated serum IgE levels. Due to the high rates of morbidity and mortality, as well as the potential curability through hematopoietic stem cell transplantation (HSCT), early and accurate differential diagnosis of this syndrome is crucial for optimal management and improved prognosis. Flow cytometry tests can be beneficial for early diagnosis of many inborn errors of immunity (IEIs), including this syndrome. This study, conducted for the first time on Iranian patients, investigated the expression of the DOCK8 protein. DOCK8 expression was assessed by flow cytometry in 14 patients (6 males and 8 females) with a clinical diagnosis of DOCK8 deficiency. The diagnosis was ultimately confirmed through genetic testing. The results showed that DOCK8 expression in patients was significantly lower compared to the healthy control group. Flow cytometric evaluation of DOCK8 protein expression offers a rapid and efficient diagnostic method with a sensitive detection range suitable for many cases. This approach can facilitate the diagnosis of DOCK8 deficiency, thereby enabling timely and effective disease management.
- Open Access
- 9 July 2025
- Published by Springer Nature in The Egyptian Journal of Otolaryngology
- Vol. 41 (1) , 1-6
Evaluation of Meniere’s disease, allergy, and their association in a group of patients with vertigo using electrocochleography and skin prick test
Background: Meniere’s disease is an idiopathic disorder of the inner ear characterized by episodic vertigo, tinnitus, fluctuating hearing loss, and aural fullness. Allergic disorders have been implicated among the heterogeneous causative factors of Meniere’s disease. Here, we aimed to evaluate the different types of allergy in Meniere disease and analyze the association of several characteristics between allergic and non-allergic groups. Methods: The 53 of the 385 patients with definite Meniere’s disease based on definite Meniere’s disease criteria which confirmed by Electrocochleography(ECOG) test was included in this study. A questionnaire was used to obtain the required data. ECOG and skin prick test were performed in all the participants. Those fulfilling the clinical criteria alongside having a summating potential/action potential ratio of ≥ 0.5 in electrocochleogram were considered as having Meniere’s disease. Results: Twenty-five of 53 Meniere patients (47.2%) showed different types of allergy. Inhalant allergy 25 (47.2%) and food allergy 8 (15.1%) were the most prevalent allergy types among Meniere patients. Among the underlying diseases, the prevalence of tinnitus was reported in 92% of the allergic patients. Moreover, the family history of Meniere disease and tinnitus were significantly associated with allergy. The pattern of threshold elevation showed that the flat pattern in allergic group and the low pattern in non-allergic group were significantly more prevalent. Conclusion: In this study, about half of Meniere patients showed different types of allergy by predominance of inhalant allergy. Tinnitus and Meniere’s family history are significantly more common in Meniere’s patients with allergy. So, allergy control in Meniere patients would be helpful on the treatment process.
- 9 July 2025
- Published by Springer Nature in The Egyptian Journal of Otolaryngology
- Vol. 41 (1) , 1-6
Open AccessEvaluation of Meniere’s disease, allergy, and their association in a group of patients with vertigo using electrocochleography and skin prick test
Background: Meniere’s disease is an idiopathic disorder of the inner ear characterized by episodic vertigo, tinnitus, fluctuating hearing loss, and aural fullness. Allergic disorders have been implicated among the heterogeneous causative factors of Meniere’s disease. Here, we aimed to evaluate the different types of allergy in Meniere disease and analyze the association of several characteristics between allergic and non-allergic groups. Methods: The 53 of the 385 patients with definite Meniere’s disease based on definite Meniere’s disease criteria which confirmed by Electrocochleography(ECOG) test was included in this study. A questionnaire was used to obtain the required data. ECOG and skin prick test were performed in all the participants. Those fulfilling the clinical criteria alongside having a summating potential/action potential ratio of ≥ 0.5 in electrocochleogram were considered as having Meniere’s disease. Results: Twenty-five of 53 Meniere patients (47.2%) showed different types of allergy. Inhalant allergy 25 (47.2%) and food allergy 8 (15.1%) were the most prevalent allergy types among Meniere patients. Among the underlying diseases, the prevalence of tinnitus was reported in 92% of the allergic patients. Moreover, the family history of Meniere disease and tinnitus were significantly associated with allergy. The pattern of threshold elevation showed that the flat pattern in allergic group and the low pattern in non-allergic group were significantly more prevalent. Conclusion: In this study, about half of Meniere patients showed different types of allergy by predominance of inhalant allergy. Tinnitus and Meniere’s family history are significantly more common in Meniere’s patients with allergy. So, allergy control in Meniere patients would be helpful on the treatment process.
- Open Access
- 31 December 2024
- Published by Maad Rayan Publishing Company in Journal of Research in Clinical Medicine
- Vol. 12 (1) , 40
Anti-leukotriene compared to inhaled corticosteroid for recurrent wheezing in children under five years of age: A randomized clinical trial
Introduction: Asthma is the common chronic disease in childhood. One of the major symptoms of asthma in children is wheezing. According to the international guidelines, inhaled corticosteroid (ICS) is prescribed for treating recurrent wheezing in children less than five years. However, due to poor adherence, high cost, and possible side effects of ICS in young children, anti-leukotrienes are recommended as a safe initial treatment for recurrent wheezing. Therefore, we performed this study to compare anti-leukotriene versus ICS in treating recurrent wheezing in children less than five years. Methods: We enrolled 68 patients less than five years old with recurrent wheezing (more than three times over the past year) and mild persistent asthma in this randomized controlled clinical trial. The patients were randomly divided in a 1:1 ratio into two groups. Group 1 was treated by ICS 50 mcg twice daily and group 2 was received montelukast 4 mg granules daily. The patients followed up for six months and the results of the two groups were compared. Results: Thirty-four of 68 patients received montelukast and 34 patients received ICS. In montelukast and ICS group, 23 (68%) and 20 (59%) patients were boys, respectively. The frequency of wheezing decreased significantly in patients receiving montelukast (P<0.001) as well as ICS (P<0.001). However, there were no differences between two groups in the efficacy of treatment (P=0.38). Conclusion: In children less than five years with mild persistent asthma, both montelukast and ICS were effective with no differences between groups in the efficacy of treatment.
- 31 December 2024
- Published by Maad Rayan Publishing Company in Journal of Research in Clinical Medicine
- Vol. 12 (1) , 40
Open AccessAnti-leukotriene compared to inhaled corticosteroid for recurrent wheezing in children under five years of age: A randomized clinical trial
Introduction: Asthma is the common chronic disease in childhood. One of the major symptoms of asthma in children is wheezing. According to the international guidelines, inhaled corticosteroid (ICS) is prescribed for treating recurrent wheezing in children less than five years. However, due to poor adherence, high cost, and possible side effects of ICS in young children, anti-leukotrienes are recommended as a safe initial treatment for recurrent wheezing. Therefore, we performed this study to compare anti-leukotriene versus ICS in treating recurrent wheezing in children less than five years. Methods: We enrolled 68 patients less than five years old with recurrent wheezing (more than three times over the past year) and mild persistent asthma in this randomized controlled clinical trial. The patients were randomly divided in a 1:1 ratio into two groups. Group 1 was treated by ICS 50 mcg twice daily and group 2 was received montelukast 4 mg granules daily. The patients followed up for six months and the results of the two groups were compared. Results: Thirty-four of 68 patients received montelukast and 34 patients received ICS. In montelukast and ICS group, 23 (68%) and 20 (59%) patients were boys, respectively. The frequency of wheezing decreased significantly in patients receiving montelukast (P<0.001) as well as ICS (P<0.001). However, there were no differences between two groups in the efficacy of treatment (P=0.38). Conclusion: In children less than five years with mild persistent asthma, both montelukast and ICS were effective with no differences between groups in the efficacy of treatment.
- Open Access
- 1 March 2024
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 383 (6686) , eadh4059
The immunopathological landscape of human pre-TCRα deficiency: From rare to common variants
We describe humans with rare biallelic loss-of-function PTCRA variants impairing pre–α T cell receptor (pre-TCRα) expression. Low circulating naive αβ T cell counts at birth persisted over time, with normal memory αβ and high γδ T cell counts. Their TCRα repertoire was biased, which suggests that noncanonical thymic differentiation pathways can rescue αβ T cell development. Only a minority of these individuals were sick, with infection, lymphoproliferation, and/or autoimmunity. We also report that 1 in 4000 individuals from the Middle East and South Asia are homozygous for a common hypomorphic PTCRA variant. They had normal circulating naive αβ T cell counts but high γδ T cell counts. Although residual pre-TCRα expression drove the differentiation of more αβ T cells, autoimmune conditions were more frequent in these patients compared with the general population.
- 1 March 2024
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 383 (6686) , eadh4059
Open AccessThe immunopathological landscape of human pre-TCRα deficiency: From rare to common variants
We describe humans with rare biallelic loss-of-function PTCRA variants impairing pre–α T cell receptor (pre-TCRα) expression. Low circulating naive αβ T cell counts at birth persisted over time, with normal memory αβ and high γδ T cell counts. Their TCRα repertoire was biased, which suggests that noncanonical thymic differentiation pathways can rescue αβ T cell development. Only a minority of these individuals were sick, with infection, lymphoproliferation, and/or autoimmunity. We also report that 1 in 4000 individuals from the Middle East and South Asia are homozygous for a common hypomorphic PTCRA variant. They had normal circulating naive αβ T cell counts but high γδ T cell counts. Although residual pre-TCRα expression drove the differentiation of more αβ T cells, autoimmune conditions were more frequent in these patients compared with the general population.
- Open Access
- 18 February 2024
- Published by Maad Rayan Publishing Company in Medical Journal of Tabriz University of Medical Sciences
Clinical findings of patients with Kawasaki disease manifestations in COVID-19 pandemic in Tabriz, Iran
Background. Kawasaki disease is an acute and rare febrile disease that affects children and is characterized by conjunctivitis, redness of the lips and mouth, diffuse skin lesions, edema and redness of the hands and feet, and cervical lymphadenopathy. Since the start of the COVID-19 pandemic, Kawasaki disease has become much more prevalent and has more diverse manifestations. Methods. This retrospective cohort study included patients diagnosed with Kawasaki symptoms between January and October 2021 at the Tabriz Children's Education and Therapeutic Center. The diagnosis was made using the guidelines of the American Heart Association (2017) and the American College of Rheumatology. Results. All referred patients had fever, and additional symptoms may include skin involvement (93%), mucosal involvement (87%), end changes in the peripheral exterimities in the form of erythema and scaling (75%), gastrointestinal manifestations (51%), cardiac manifestations (42%), followed by respiratory (27%), and finally cervical lymphadenopathy (18%). Conclusion. Manifestations of Kawasaki disease during the COVID-19 pandemic can be much more diverse and severe. Knowing the variety of clinical symptoms and uncommon findings of Kawasaki disease in these patients can help to early distinguishing between Kawasaki and Kawasaki like disease and prevent the progression of the disease. Practical Implications. It was noteworthy that patients with complete Kawasaki manifestations were less than five years old. The age range of the patients was between 11 months and 13 years, and the average age range was between 5 and 6 years (65±37 months).
- 18 February 2024
- Published by Maad Rayan Publishing Company in Medical Journal of Tabriz University of Medical Sciences
Open AccessClinical findings of patients with Kawasaki disease manifestations in COVID-19 pandemic in Tabriz, Iran
Background. Kawasaki disease is an acute and rare febrile disease that affects children and is characterized by conjunctivitis, redness of the lips and mouth, diffuse skin lesions, edema and redness of the hands and feet, and cervical lymphadenopathy. Since the start of the COVID-19 pandemic, Kawasaki disease has become much more prevalent and has more diverse manifestations. Methods. This retrospective cohort study included patients diagnosed with Kawasaki symptoms between January and October 2021 at the Tabriz Children's Education and Therapeutic Center. The diagnosis was made using the guidelines of the American Heart Association (2017) and the American College of Rheumatology. Results. All referred patients had fever, and additional symptoms may include skin involvement (93%), mucosal involvement (87%), end changes in the peripheral exterimities in the form of erythema and scaling (75%), gastrointestinal manifestations (51%), cardiac manifestations (42%), followed by respiratory (27%), and finally cervical lymphadenopathy (18%). Conclusion. Manifestations of Kawasaki disease during the COVID-19 pandemic can be much more diverse and severe. Knowing the variety of clinical symptoms and uncommon findings of Kawasaki disease in these patients can help to early distinguishing between Kawasaki and Kawasaki like disease and prevent the progression of the disease. Practical Implications. It was noteworthy that patients with complete Kawasaki manifestations were less than five years old. The age range of the patients was between 11 months and 13 years, and the average age range was between 5 and 6 years (65±37 months).
- Open Access
- 21 February 2023
- Published by Springer Nature in Allergy, Asthma & Clinical Immunology
- Vol. 19 (1) , 1-12
Demographic, clinical, immunological, and molecular features of iranian national cohort of patients with defect in DCLRE1C gene
Background: DCLRE1C gene mutation leads to Artemis deficiency, a severe form of combined immunodeficiency (SCID). Impaired DNA repair and block in early adaptive immunity maturation results in T-B-NK+ immunodeficiency associated with radiosensitivity. Recurrent infections early in life are the main characteristic of Artemis patients. Method: Among 5373 registered patients, 9 Iranian patients (33.3% female) with confirmed DCLRE1C mutation were identified since 1999–2022. The demographic, clinical, immunological and genetic features were collected through retrospective investigation of medical records and using next generation sequencing. Results: Seven patients were born in a consanguineous family (77.8%). The median age of onset was 6.0 (5.0–17.0) months. Severe combined immunodeficiency (SCID) was clinically detected at a median (IQR) age of 7.0 (6.0–20.5) months, following a median diagnostic delay of 2.0 (1.0–3.5) months The most typical first presentation was pneumonia (44.4%) and otitis media (3.33%), followed by BCG lymphadenitis (22.2%) and gastroenteritis (11.1%). The most prevalent manifestations were respiratory tract infections (including otitis media) (66.6%) and chronic diarrhea (66.6%). In addition, juvenile idiopathic arthritis (P5) and celiac disease and idiopathic thrombocytopenic purpura (P9) as autoimmune disorders were reported in 2 patients. All patients had reduced B CD19+ and CD4+ cell counts. IgA deficiency occurred in 77.8% of individuals. Conclusion: Recurrent infections particulary respiratory tract infection and chronic diarrhea during the first months of life in patients born to consanguineous parents should raise the suspicion for inborn errors of immunity, even in the presence of normal growth and development.
- 21 February 2023
- Published by Springer Nature in Allergy, Asthma & Clinical Immunology
- Vol. 19 (1) , 1-12
Open AccessDemographic, clinical, immunological, and molecular features of iranian national cohort of patients with defect in DCLRE1C gene
Background: DCLRE1C gene mutation leads to Artemis deficiency, a severe form of combined immunodeficiency (SCID). Impaired DNA repair and block in early adaptive immunity maturation results in T-B-NK+ immunodeficiency associated with radiosensitivity. Recurrent infections early in life are the main characteristic of Artemis patients. Method: Among 5373 registered patients, 9 Iranian patients (33.3% female) with confirmed DCLRE1C mutation were identified since 1999–2022. The demographic, clinical, immunological and genetic features were collected through retrospective investigation of medical records and using next generation sequencing. Results: Seven patients were born in a consanguineous family (77.8%). The median age of onset was 6.0 (5.0–17.0) months. Severe combined immunodeficiency (SCID) was clinically detected at a median (IQR) age of 7.0 (6.0–20.5) months, following a median diagnostic delay of 2.0 (1.0–3.5) months The most typical first presentation was pneumonia (44.4%) and otitis media (3.33%), followed by BCG lymphadenitis (22.2%) and gastroenteritis (11.1%). The most prevalent manifestations were respiratory tract infections (including otitis media) (66.6%) and chronic diarrhea (66.6%). In addition, juvenile idiopathic arthritis (P5) and celiac disease and idiopathic thrombocytopenic purpura (P9) as autoimmune disorders were reported in 2 patients. All patients had reduced B CD19+ and CD4+ cell counts. IgA deficiency occurred in 77.8% of individuals. Conclusion: Recurrent infections particulary respiratory tract infection and chronic diarrhea during the first months of life in patients born to consanguineous parents should raise the suspicion for inborn errors of immunity, even in the presence of normal growth and development.
- Open Access
- 29 May 2022
- Published by Maad Rayan Publishing Company in Journal of Dental Research, Dental Clinics, Dental Prospects
- Vol. 16 (1) , 18-23
Comparison of superior airway dimensions and cephalometric anatomic landmarks between 8–12-year-old children with obstructive sleep apnea and healthy children using CBCT images
Background. The etiology of obstructive sleep apnea (OSA) syndrome in children significantly differs from adults. In previous studies, only some of the indices have been investigated using CBCT. This study compares all the measurable indices of airway dimensions and anatomical cephalometric landmarks between children with OSA and healthy ones using cone-beam computed tomography (CBCT). Methods. Dimensions of the airway and cephalometric values were measured on CBCT scans of 50 children aged 8–12 (25 patients with OSA and 25 healthy subjects) and then compared between the two groups. The results of this study were analyzed with independent t test using SPSS 17 at a significance level of P<0.05. Results. Area, length, volume, anteroposterior length, and size of the upper airway in subjects with OSA were lower than those in healthy children, while the average values of SNA, SNB, and ANB in the OSA group were higher than those in the healthy group (P=0.366, P=0.012, and P=0.114, respectively). Also, BaSN, PNS/AD1, and PNS/AD2 measurements in subjects with OSA were lower than healthy subjects (P=0.041, P=0.913, and P=0.015, respectively). In addition, the width and anteroposterior length of the upper airway, SNB, BaSN, PNS/AD1, and PNS/AD2 indices were significantly different between the healthy group and those with OSA (P<0.05). Conclusion. Reduced upper airway dimensions, adenoid tissue enlargement, and cranial base flexion might play an important role in OSA development in children. However, most skeletal variables, such as the anteroposterior relationship of jaws and jaw rotation, were not significantly different between the two groups.
- 29 May 2022
- Published by Maad Rayan Publishing Company in Journal of Dental Research, Dental Clinics, Dental Prospects
- Vol. 16 (1) , 18-23
Open AccessComparison of superior airway dimensions and cephalometric anatomic landmarks between 8–12-year-old children with obstructive sleep apnea and healthy children using CBCT images
Background. The etiology of obstructive sleep apnea (OSA) syndrome in children significantly differs from adults. In previous studies, only some of the indices have been investigated using CBCT. This study compares all the measurable indices of airway dimensions and anatomical cephalometric landmarks between children with OSA and healthy ones using cone-beam computed tomography (CBCT). Methods. Dimensions of the airway and cephalometric values were measured on CBCT scans of 50 children aged 8–12 (25 patients with OSA and 25 healthy subjects) and then compared between the two groups. The results of this study were analyzed with independent t test using SPSS 17 at a significance level of P<0.05. Results. Area, length, volume, anteroposterior length, and size of the upper airway in subjects with OSA were lower than those in healthy children, while the average values of SNA, SNB, and ANB in the OSA group were higher than those in the healthy group (P=0.366, P=0.012, and P=0.114, respectively). Also, BaSN, PNS/AD1, and PNS/AD2 measurements in subjects with OSA were lower than healthy subjects (P=0.041, P=0.913, and P=0.015, respectively). In addition, the width and anteroposterior length of the upper airway, SNB, BaSN, PNS/AD1, and PNS/AD2 indices were significantly different between the healthy group and those with OSA (P<0.05). Conclusion. Reduced upper airway dimensions, adenoid tissue enlargement, and cranial base flexion might play an important role in OSA development in children. However, most skeletal variables, such as the anteroposterior relationship of jaws and jaw rotation, were not significantly different between the two groups.
- Open Access
- 24 February 2021
- Published by Maad Rayan Publishing Company in Medical Journal of Tabriz University of Medical Sciences and Health Services
- Vol. 42 (6) , 659-666
The survey of clinical manifestations of infants with cow’s milk allergy according to the COMISS questionnaire
Background: Cow’s milk is one of the first foods added to infants’ diet and cow’s milk allergy (CMA) is the most common food allergy in the first year of life. The aim of this study was to survey the frequency of infants with cow’s milk allergy using COMISS questionnaire. Methods: In a cross-sectional, descriptive study, 100 infants were selected by a convenient method. Demographic information and clinical manifestations were completed based on COMISS Questionnaire for all infants. Data were analyzed using chi-square and independent t-test. Results: The finding of this study shows that from 100 infants (51 males, 49 females), with a mean age of 3.5 ± 1.4, 61% of them were breastfed, 30% were fed both cow’s milk and breast milk, and 9% were fed only cow’s milk. The probability of cow’s milk allergy using the COMISS Questionnaire was positive in 8% of infants. According to the criteria of this Questionnaire, 65% of infants acquired a score of 0-5, 27% scored 6-11, and 8% scored 12 and above A significant association was found between cow’s milk allergy and infant’s diet (p <0.001). A significant association was also found between growth index (weight p=0.05, height p=0.02, and head circumstance p=0.03) and CMA. Conclusion: It seems that using non-invasive methods such as COMISS Questionnaire can be helpful for the diagnosis of CMA and also breastfeeding might be reducing the allergy to cow’s milk.
- 24 February 2021
- Published by Maad Rayan Publishing Company in Medical Journal of Tabriz University of Medical Sciences and Health Services
- Vol. 42 (6) , 659-666
Open AccessThe survey of clinical manifestations of infants with cow’s milk allergy according to the COMISS questionnaire
Background: Cow’s milk is one of the first foods added to infants’ diet and cow’s milk allergy (CMA) is the most common food allergy in the first year of life. The aim of this study was to survey the frequency of infants with cow’s milk allergy using COMISS questionnaire. Methods: In a cross-sectional, descriptive study, 100 infants were selected by a convenient method. Demographic information and clinical manifestations were completed based on COMISS Questionnaire for all infants. Data were analyzed using chi-square and independent t-test. Results: The finding of this study shows that from 100 infants (51 males, 49 females), with a mean age of 3.5 ± 1.4, 61% of them were breastfed, 30% were fed both cow’s milk and breast milk, and 9% were fed only cow’s milk. The probability of cow’s milk allergy using the COMISS Questionnaire was positive in 8% of infants. According to the criteria of this Questionnaire, 65% of infants acquired a score of 0-5, 27% scored 6-11, and 8% scored 12 and above A significant association was found between cow’s milk allergy and infant’s diet (p <0.001). A significant association was also found between growth index (weight p=0.05, height p=0.02, and head circumstance p=0.03) and CMA. Conclusion: It seems that using non-invasive methods such as COMISS Questionnaire can be helpful for the diagnosis of CMA and also breastfeeding might be reducing the allergy to cow’s milk.
- Open Access
- 23 October 2020
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 35 (2) , e23637
Identification of Cytochrome b‐245, beta‐chain gene mutations, and clinical presentations in Iranian patients with X‐linked chronic granulomatous disease
Background: X‐linked chronic granulomatous disease (X‐CGD) is an immunodeficiency disorder caused by defects in the gp91 phox subunit that leads to life‐threatening infections. We aimed to identify CYBB gene mutations and study clinical phenotypes in Iranian patients with probable X‐CGD. Methods: We studied four unrelated Iranian patients with probable X‐CGD and their families recruited in several years. We isolated genomic DNA from whole blood and performed Sanger sequencing in the CYBB gene's coding and flanking regions. We also performed pathogenicity predictions using in silico tools. Results: We detected four different mutations, including a novel insertion mutation in exon 5 (p.Ile117AsnfsX6), in the patient. Bioinformatics analysis confirmed the pathogenic effect of this mutation. We predicted protein modeling and demonstrated lost functional domains. The patient with the insertion mutation presented pneumonia and acute sinusitis during his life. We also detected three other known nonsense mutations (p.Arg157Ter, p.Arg226Ter, and p.Trp424Ter) in the CYBB gene. The patient with p.Arg157Ter developed lymphadenitis and pneumonia. Moreover, the patient with inflammatory bowel disease showed p.Arg226Ter and the patient with tuberculosis presented p.Trp424Ter. We detected different clinical features in the patients compared to other Iranian patients with the same mutations. Conclusion: Our results expand the genetic database of patients with X‐CGD from Iran and make it much easier and faster to identify patients with X‐CGD. Our results also help to detect carriers and enable prenatal diagnosis in high‐risk families as a cost‐effective strategy.
- 23 October 2020
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 35 (2) , e23637
Open AccessIdentification of Cytochrome b‐245, beta‐chain gene mutations, and clinical presentations in Iranian patients with X‐linked chronic granulomatous disease
Background: X‐linked chronic granulomatous disease (X‐CGD) is an immunodeficiency disorder caused by defects in the gp91 phox subunit that leads to life‐threatening infections. We aimed to identify CYBB gene mutations and study clinical phenotypes in Iranian patients with probable X‐CGD. Methods: We studied four unrelated Iranian patients with probable X‐CGD and their families recruited in several years. We isolated genomic DNA from whole blood and performed Sanger sequencing in the CYBB gene's coding and flanking regions. We also performed pathogenicity predictions using in silico tools. Results: We detected four different mutations, including a novel insertion mutation in exon 5 (p.Ile117AsnfsX6), in the patient. Bioinformatics analysis confirmed the pathogenic effect of this mutation. We predicted protein modeling and demonstrated lost functional domains. The patient with the insertion mutation presented pneumonia and acute sinusitis during his life. We also detected three other known nonsense mutations (p.Arg157Ter, p.Arg226Ter, and p.Trp424Ter) in the CYBB gene. The patient with p.Arg157Ter developed lymphadenitis and pneumonia. Moreover, the patient with inflammatory bowel disease showed p.Arg226Ter and the patient with tuberculosis presented p.Trp424Ter. We detected different clinical features in the patients compared to other Iranian patients with the same mutations. Conclusion: Our results expand the genetic database of patients with X‐CGD from Iran and make it much easier and faster to identify patients with X‐CGD. Our results also help to detect carriers and enable prenatal diagnosis in high‐risk families as a cost‐effective strategy.
- Open Access
- 26 June 2020
- Published by Salvia Medical Sciences Ltd in Galen Medical Journal
- Vol. 9, e1918
Effect of Probiotics on Allergic Rhinitis: A Randomized, Controlled, Clinical Trial
Background: Allergic rhinitis (AR) is one of the most common diseases in the world and affects about 10-50% of the general population. Probiotics are live microorganisms that help the normal state of the intestine, and if prescribed correctly, they can stimulate the mucosal immune system to prevent inflammatory symptoms of allergy and atopy. The present study aims to investigate the role of probiotics in the treatment of AR when added to standard therapy as adjuvant agents. Materials and Methods: In this clinical trial study, 28 patients older than 15 years with AR randomly divided into probiotics and control groups. The probiotics group received standard therapy for AR accompanied by probiotic capsules every 12 hours for eight weeks, whereas the control group received standard therapy for AR with placebo capsules as the same protocol. Data were analyzed using SPSS Version 23 (IBM Corporation, Armonk, NY, USA) and, the P-value less than 0.05 was considered statistically significant. Results: In the probiotics group, 14.3% of patients had sneezing at the baseline, which significantly decreased to 4.6% (PConclusion: Based on the results of this clinical trial, the use of probiotics had no significant effect on the outcome of patients with AR. [GMJ.2020;9:e1918]
- 26 June 2020
- Published by Salvia Medical Sciences Ltd in Galen Medical Journal
- Vol. 9, e1918
Open AccessEffect of Probiotics on Allergic Rhinitis: A Randomized, Controlled, Clinical Trial
Background: Allergic rhinitis (AR) is one of the most common diseases in the world and affects about 10-50% of the general population. Probiotics are live microorganisms that help the normal state of the intestine, and if prescribed correctly, they can stimulate the mucosal immune system to prevent inflammatory symptoms of allergy and atopy. The present study aims to investigate the role of probiotics in the treatment of AR when added to standard therapy as adjuvant agents. Materials and Methods: In this clinical trial study, 28 patients older than 15 years with AR randomly divided into probiotics and control groups. The probiotics group received standard therapy for AR accompanied by probiotic capsules every 12 hours for eight weeks, whereas the control group received standard therapy for AR with placebo capsules as the same protocol. Data were analyzed using SPSS Version 23 (IBM Corporation, Armonk, NY, USA) and, the P-value less than 0.05 was considered statistically significant. Results: In the probiotics group, 14.3% of patients had sneezing at the baseline, which significantly decreased to 4.6% (PConclusion: Based on the results of this clinical trial, the use of probiotics had no significant effect on the outcome of patients with AR. [GMJ.2020;9:e1918]